- Home
- IVP vs INM Comparison
IVP vs INM Comparison
Compare IVP & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVP
- INM
- Stock Information
- Founded
- IVP 2020
- INM 1981
- Country
- IVP United States
- INM Canada
- Employees
- IVP N/A
- INM N/A
- Industry
- IVP Diversified Commercial Services
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- IVP Miscellaneous
- INM Health Care
- Exchange
- IVP Nasdaq
- INM Nasdaq
- Market Cap
- IVP 3.5M
- INM 4.1M
- IPO Year
- IVP 2023
- INM N/A
- Fundamental
- Price
- IVP $0.77
- INM $1.70
- Analyst Decision
- IVP
- INM
- Analyst Count
- IVP 0
- INM 0
- Target Price
- IVP N/A
- INM N/A
- AVG Volume (30 Days)
- IVP 107.1K
- INM 61.5K
- Earning Date
- IVP 11-12-2025
- INM 11-06-2025
- Dividend Yield
- IVP N/A
- INM N/A
- EPS Growth
- IVP N/A
- INM N/A
- EPS
- IVP N/A
- INM N/A
- Revenue
- IVP $15,292,904.00
- INM $4,798,116.00
- Revenue This Year
- IVP N/A
- INM N/A
- Revenue Next Year
- IVP N/A
- INM N/A
- P/E Ratio
- IVP N/A
- INM N/A
- Revenue Growth
- IVP N/A
- INM N/A
- 52 Week Low
- IVP $0.63
- INM $1.56
- 52 Week High
- IVP $6.38
- INM $8.27
- Technical
- Relative Strength Index (RSI)
- IVP 41.66
- INM 36.70
- Support Level
- IVP $0.67
- INM $1.59
- Resistance Level
- IVP $0.85
- INM $1.91
- Average True Range (ATR)
- IVP 0.05
- INM 0.10
- MACD
- IVP -0.01
- INM 0.00
- Stochastic Oscillator
- IVP 46.90
- INM 29.47
About IVP Inspire Veterinary Partners Inc.
Inspire Veterinary Partners Inc owns and operates veterinary hospitals throughout the United States. The company specializes in small animal general practice hospitals that serve all manner of companion pets, emphasizing canine and feline breeds.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.